Publications by authors named "P Killian"

Background: Rising costs are a challenge for healthcare systems. To keep expenditure for drugs under control, in many healthcare systems, drug prescribing is continuously monitored. The Bavarian Drug Agreement (German: Wirkstoffvereinbarung or WSV) for the ambulatory sector in Bavaria (the federal state of Germany) was developed for this purpose.

View Article and Find Full Text PDF
Article Synopsis
  • The Bavarian Drug Agreement aims to manage rising drug costs by setting prescribing targets for preferred and generic medications, with healthcare providers receiving feedback and facing potential penalties based on their performance.
  • Analysis of prescribing data from early 2018 showed that while high-volume drug targets are generally met, many less common targets are often missed, particularly in pediatric care.
  • Generic drugs tend to be prescribed more effectively than recommended medications, as prescribers struggle with new, expensive options that may provide unclear benefits, leading to challenges in meeting targets.
View Article and Find Full Text PDF

Background: In 2014 a new system for drug expenditures, the Wirkstoffvereinbarung (WSV, English: Active substance agreement) was implemented in Bavaria. In pre-defined indication groups, economic prescription of medications shall be enabled based on the selection, quantity, and proportion of an individual drug. Ambulatory care physicians receive quarterly trend reports on their prescribing behavior.

View Article and Find Full Text PDF

Background: With the introduction of tumor necrosis factor (TNF) alpha inhibitors, the treatment of inflammatory rheumatic diseases (IRD) has undergone a fundamental change. Several of the originally high-priced biologics are now accessible as lower cost biosimilars, removing a significant impediment to prescription.

Objective: The present study investigated whether the availability of biosimilars is associated with an improvement in the care of IRD.

View Article and Find Full Text PDF

Background And Objectives: In 2014, the Association of Statutory Health Insurance Physicians of Bavaria introduced the active substance agreement (WSV) for the transparent control of pharmaceutical expenditure within the framework of the efficiency principle (§ 12 of the Fifth Book of the German Social Code [SGB V]). It replaced the prescribing target scheme. Regarding the role of the WSV, the article presents the reasons of the general practitioners (GPs) for or against a further prescription of drugs from the hospital.

View Article and Find Full Text PDF